X4 Pharmaceuticals Inc
NASDAQ:XFOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
B
|
Boston Beer Company Inc
SWB:BBEA
|
US |
|
NTG Nordic Transport Group AS
F:NRSA
|
DK |
|
Aem Holdings Ltd
SGX:AWX
|
SG |
|
Xtek Ltd
ASX:XTE
|
AU |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
F
|
First Advantage Corp
NASDAQ:FA
|
US |
Wall St Price Targets
XFOR Price Targets Summary
X4 Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
XFOR is 11.9 USD with a low forecast of 10.1 USD and a high forecast of 13.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XFOR's stock price target?
Price Target
11.9
USD
According to Wall Street analysts, the average 1-year price target for
XFOR is 11.9 USD with a low forecast of 10.1 USD and a high forecast of 13.65 USD.
What is the Revenue forecast for X4 Pharmaceuticals Inc?
Projected CAGR
83%
The compound annual growth rate for Revenue over the next 5 years is 83%.